Our results revealed that ampelopsin induces cell proliferation inhibition and apoptosis in HL60 AML and K562 CML cells by downregulating AKT and NF-κB signaling pathways. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.